Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E French

Showing results (661-670 of 778) with videos related to

Pageof 78
Sort By:
Journal for Immunotherapy of Cancer|June 12, 2026
Extracorporeal photopheresis versus systemic immunosuppression for treatment of immune-related adverse events: clinical outcomes from the prospective two-arm PRIA studyLisa Wein, Carolin Ertl, Theresa Ruf, et al.
Immunity|January 1, 1997
TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95)J L Bodmer, K Burns, P Schneider, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 6, 2003
The utility of genetically modified mouse assays for identifying human carcinogens: a basic understanding and path forward. The Alternatives to Carcinogenicity Testing Committee ILSI HESIJames MacDonald, John E French, Ronald J Gerson, et al.
Addiction (Abingdon, England)|November 3, 2020
Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta-analysisClaire F Ferraro, Daniel E Stewart, Jason Grebely, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 4, 2017
Radiotherapy-induced reactivation of neurotrophic human herpes viruses: Overview and managementMarigdalia K Ramirez-Fort, Jianying Zeng, Amir Feily, et al.
Cancers|June 26, 2025
Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints TargetedLukas Kraehenbuehl, Nicola Winkelbeiner, Patrick Turko, et al.
The Lancet. Respiratory Medicine|October 13, 2022
Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trialNicola K Love, Derren R Ready, Charlie Turner, et al.
Nature Communications|January 25, 2024
MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoidesYun-Tsan Chang, Pacôme Prompsy, Susanne Kimeswenger, et al.
Oncoimmunology|June 7, 2018
PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinomaDagmar Kollmann, Desislava Ignatova, Julia Jedamzik, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 4, 2011
The utility of naphthyl-keratin adducts as biomarkers for jet-fuel exposureJuei-Chuan C Kang-Sickel, Mary Ann Butler, Lynn Frame, et al.
Pageof 78

Showing results (661-670 of 778) with videos related to

Sort By:
Pageof 78
Journal for Immunotherapy of Cancer|June 12, 2026
Extracorporeal photopheresis versus systemic immunosuppression for treatment of immune-related adverse events: clinical outcomes from the prospective two-arm PRIA studyLisa Wein, Carolin Ertl, Theresa Ruf, et al.
Immunity|January 1, 1997
TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95)J L Bodmer, K Burns, P Schneider, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 6, 2003
The utility of genetically modified mouse assays for identifying human carcinogens: a basic understanding and path forward. The Alternatives to Carcinogenicity Testing Committee ILSI HESIJames MacDonald, John E French, Ronald J Gerson, et al.
Addiction (Abingdon, England)|November 3, 2020
Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta-analysisClaire F Ferraro, Daniel E Stewart, Jason Grebely, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 4, 2017
Radiotherapy-induced reactivation of neurotrophic human herpes viruses: Overview and managementMarigdalia K Ramirez-Fort, Jianying Zeng, Amir Feily, et al.
Cancers|June 26, 2025
Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints TargetedLukas Kraehenbuehl, Nicola Winkelbeiner, Patrick Turko, et al.
The Lancet. Respiratory Medicine|October 13, 2022
Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trialNicola K Love, Derren R Ready, Charlie Turner, et al.
Nature Communications|January 25, 2024
MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoidesYun-Tsan Chang, Pacôme Prompsy, Susanne Kimeswenger, et al.
Oncoimmunology|June 7, 2018
PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinomaDagmar Kollmann, Desislava Ignatova, Julia Jedamzik, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 4, 2011
The utility of naphthyl-keratin adducts as biomarkers for jet-fuel exposureJuei-Chuan C Kang-Sickel, Mary Ann Butler, Lynn Frame, et al.
Pageof 78